Sacubitril/valsartan sodium
Signals from filings dated November 2026 – November 2026 · Last checked 15 Nov 2026
Supply outlook
↑ GROWINGIn the filings we track: 1 plant adding this molecule, 0 exit signals, 0 intermediate projects.
↑ Coming in1 plant+40 t/yr, where filed in tonnes
↓ Leaving0no drops or surrenders found
⇄ Own intermediates0no KSM projects found
Furthest stageEIA approvedapproval is not production
Signals
↑ NEW AT SITE
+40 t/yrZhejiang Huahai Jiancheng Pharmaceutical Co., Ltd.
Donghai 6th Avenue No. 3, Taizhou Bay Economic and Technological Development Zone, Zhejiang
- ✓ EIA filed
- ✓ Approval notice
- ✓ EIA approved · 4 Nov 2026
- Next: completion check
- DMF / CEP
Same project as amlodipine besylate, sacubitril sodium and sertraline. Approval No. 台环建〔2026〕80号, 4 Nov 2026. Source: EIA approval, Taizhou Ecology and Environment Bureau
Who makes Sacubitril/valsartan sodium today: 7 listings
Current manufacturers with US DMF and CEP status, plant addresses and contacts.
| Manufacturer | Country | US DMF | CEP | Contact |
|---|---|---|---|---|
| Dr Reddy's Laboratories Ltd | India | ✓ | — | In database |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Israel | ✓ | — | In database |
| ZHUHAI RUNDU PHARMACEUTICAL CO LTD | China | ✓ | — | In database |
| + 4 more listings in api-fdf.com → | ||||
Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.
Follow Sacubitril/valsartan sodium
Get an email when a new filing adds, cuts or moves this molecule to the next stage.